Impact of bevacizumab added to temozolomide-chemoradiation on time to health-related quality of life deterioration in unresectable glioblastoma: results of a phase II randomized clinical trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of bevacizumab added to temozolomide-chemoradiation on time to health-related quality of life deterioration in unresectable glioblastoma: results of a phase II randomized clinical trial
Type de publicationJournal Article
Year of Publication2015
AuteursAnota A, Dabakuyo TSandrine, Pozet A, Paquette B, Feuvret L, Taillandier L, Frappaz D, Taillia H, Schott R, Fabbro M, Tennevet I, Ghiringhelli F, Dalban C, Skrzypski J, Chinot O, Chauffert B, Bonnetain F
JournalQUALITY OF LIFE RESEARCH
Volume24
Pagination15-16
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0962-9343